Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis

Published:2020-10-01 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Al Said Samer¹²,Kaier Klaus³,Nury Edris⁴,Alsaid Dima⁴,Meder Benjamin¹²,Gibson C. Michael⁵,Bax Jeroen⁶,Meerpohl Joerg J⁷,Katus Hugo¹²

Affiliation:

1. Department for Internal Medicine III Cardiology Angiology and Pneumology; University Hospital Heidelberg; Heidelberg Germany

2. DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim; University of Heidelberg; Heidelberg Germany

3. Institute for Medical Biometry and Statistics; Faculty of Medicine and Medical Center, University of Freiburg; Freiburg Germany

4. Institute for Evidence in Medicine, Medical Center - University of Freiburg; Faculty of Medicine, University of Freiburg; Freiburg Germany

5. Cardiology Division, Beth Israel Deaconess Medical Center; Harvard Medical School; Boston MA USA

6. Department of Cardiology; Leiden University Medical Center; Leiden Netherlands

7. Institute for Evidence in Medicine; Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg; Freiburg Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference53 articles.

1. Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement;Abdul-Jawad Altisent;JACC. Cardiovascular Interventions,2016

2. Anticoagulation in atherosclerotic disease;Al Said;Hamostaseologie,2018

3. Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis;Al Said;Cochrane Database of Systematic Reviews,2019

4. Pros and cons of new oral anticoagulants;Bauer;Hematology,2013

5. 2017 ESC/EACTS Guidelines for the management of valvular heart disease;Baumgartner;European Heart Journal,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3